Skip to main content

Table 3 Prevalence of prothrombin G20210A mutation and its association with SCD in Palestinian patients

From: Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease

Patient (n) Prothrombin G20210A Crude Adjusted
G/G G/A A/A OR (95% CI) P value OR (95% CI) P value
SS (59) 56 3 0 8.4(1.8–56.4) 0.16 6.3(1.17–33.9) 0.12
AS (25) 24 1 0 5.5(1.1–66.2) 0.13 3.71(0.46–26.1) 0.18
S/Thal (33) 29 4 0 9.4(1.9–54.4) 0.09 3.39(0.33–43.4) 0.21
Controls 112 6 0 1 1